All data are based on the daily closing price as of April 28, 2025
u

Universal Vision Biotechnology

3218.TWO
5.47 USD
0.06
+1.11%

Overview

Last close
5.47 usd
Market cap
463.24M usd
52 week high
9.36 usd
52 week low
4.85 usd
Target price
6.62 usd

Valuation

P/E
14.1261
Forward P/E
N/A
Price/Sales
3.5567
Price/Book Value
4.1169
Enterprise Value
432.79M usd
EV/Revenue
3.3225
EV/EBITDA
7.5509

Key financials

Revenue TTM
130.26M usd
Gross Profit TTM
78.04M usd
EBITDA TTM
53.56M usd
Earnings per Share
0.39 usd
Dividend
0.23 usd
Total assets
175.76M usd
Net debt
N/A usd

About

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
  • Symbol
    3218.TWO
  • Exchange
    TWO
  • Isin
    TW0003218004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Ms. Shu-Hsin Lin
  • Headquarter
    Taipei
  • Web site
    https://www.uvb.com.tw/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top